Thrombocytopenia Up With Use of Phosphate-Buffered Tirofiban

Share this content:
Thrombocytopenia Up With Use of Phosphate-Buffered Tirofiban
Thrombocytopenia Up With Use of Phosphate-Buffered Tirofiban

TUESDAY, Aug. 16, 2016 (HealthDay News) -- For patients with acute coronary syndrome, phosphate-buffered tirofiban, but not citrate-buffered tirofiban, is associated with an increased risk of thrombocytopenia, according to a study published in the Aug. 22 issue of JACC: Cardiovascular Interventions.

Marianna Adamo, M.D., from Erasmus Medical Center in Rotterdam, Netherlands, and colleagues randomized 3,232 patients to receive tirofiban or unfractionated heparin (UFH). A total of 879 patients were allocated to phosphate-buffered tirofiban and 874 to the UFH group in the early phase, and 737 and 742 patients were treated with citrate-buffered tirofiban and UFH, respectively, in the late phase.

The researchers found that patients treated with phosphate-buffered tirofiban had an increased relative risk for thrombocytopenia in the early phase (odds ratio, 3.51 [95 percent confidence interval (CI), 1.15 to 10.73] for nadir <90,000/mm³; odds ratio, 2.83 [95 percent CI, 1.11 to 7.22] for nadir <100,000/mm³). The relative risk was not increased for patients treated with citrate-buffered tirofiban in the late phase (odds ratios, 1.01 [95 percent CI, 0.20 to 5.05] and 0.99 [95 percent CI, 0.26 to 3.45], respectively). The randomization period significantly modified the effect of the treatment on platelet decrease (P for interaction = 0.024).

"Phosphate-buffered tirofiban, currently marketed as a generic drug, is associated with a higher rate of thrombocytopenia with a potentially increased risk for adverse clinical outcomes compared with citrate-buffered tirofiban," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

RSNA: Sleep Deprivation Appears to Affect Heart Function

RSNA: Sleep Deprivation Appears to Affect Heart Function

Small study finds lack of sleep affects blood pressure, heart rate in healthy volunteers

Three Low-Carb Meals a Day Can Lower Insulin Resistance

Three Low-Carb Meals a Day Can Lower Insulin ...

However, pre-meal exercising not helpful in reducing evening blood glucose levels

Augmented Reality, Gaming May Help Relieve Phantom Limb Pain

Augmented Reality, Gaming May Help Relieve Phantom Limb ...

Study finds exercising virtual limb can cut pain by as much as half

is free, fast, and customized just for you!

Already a member?

Sign In Now »